Fenbendazole, Mebendazole, and Albendazole are often mentioned together in repurposed-drug cancer research — but they are not the same drug. All three belong to the benzimidazole family and share a core mechanism, yet differ sharply in human approval status, cancer research evidence, cost, and safety profile. This guide breaks down exactly how they compare, side by side.